CCL6 deficiency significantly reduces ovalbumin-induced airway eosinophilia, mucus hypersecretion, and Th2 responses, with the CCL6-CCR1 axis serving as a key regulator in asthma pathogenesis and a promising therapeutic target (Du et al., 2021). The gene discussed is CCR1; the disease is asthma.